Genetic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist
✍ Scribed by Joannis Vamvakopoulos; Colin Green; Su Metcalfe
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 230 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Interleukin‐1 (IL‐1) is a key pro‐inflammatory cytokine that has diverse actions in the brain as a regulator of host defense responses and a mediator of inflammation. Two major agonists, IL‐1α and IL‐1β, bind to a single known functional type‐1 IL‐1 receptor (IL‐1RI) that associates wit
## Abstract Articular cartilage functions to provide a low‐friction surface for joint movement for many decades of life. Superficial zone protein (SZP) is a glycoprotein secreted by chondrocytes in the superficial layer of articular cartilage that contributes to effective boundary lubrication. In b
Interleukin-1 is a pleiotropic cytokine that has been shown previously to suppress active cell death in T cells. Two cell surface receptors for interleukin-1 have been identified and their genes cloned, type I (IL-RI) and type II (IL-RII) receptors. In the present study, we provide evidence for a ro